Richele Smart
Payments from drug & device makers
Across 143 payments — averaging $13.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$455
- Amarin Pharma, Inc.$245
- Novartis$235
- Kowa Pharmaceuticals America, Inc.$170
- Amgen$135
- Boehringer Ingelheim$126
- plus $510 from 7 others
What the payments were for
- Food & beverage$1,877100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 34 | $455 |
| Amarin Pharma, Inc. | 23 | $245 |
| Novartis | 19 | $235 |
| Kowa Pharmaceuticals America, Inc. | 16 | $170 |
| Amgen | 10 | $135 |
| Boehringer Ingelheim | 7 | $126 |
| Merck | 9 | $121 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $90 |
| Astellas Pharma US Inc | 5 | $87 |
| Esperion Therapeutics, Inc. | 4 | $65 |
| Arbor Pharmaceuticals, Inc. | 5 | $62 |
| Pfizer | 4 | $61 |
| E.r. Squibb & Sons, L.L.C. | 2 | $24 |
How this compares
$1,877 in reported general payments places this provider in the 80th percentile of 6,812 family providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 124 | $4,458 |
| Gabapentin | 206 | $3,733 |
| Tizanidine Hcl | 199 | $1,235 |
| Duloxetine Hcl | 22 | $998 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 34 | $850 |
| Methocarbamol | 62 | $820 |
| Amitriptyline Hcl | 69 | $723 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 31 | $537 |
| Diclofenac Sodium | 54 | $399 |
| Baclofen | 37 | $382 |
| Celecoxib | 12 | $336 |
| Oxycodone Hcl | 30 | $301 |
| Topiramate | 26 | $260 |
| Ibuprofen | 24 | $234 |
| Cyclobenzaprine Hcl | 25 | $169 |
Paid to pharmacies, not to this prescriber.
Other family in Dover
- Eileen FauldsLewis Center$991K
- Leigh Ann PanschDayton$670K
- Natalie BelliniMayfield Heights$582K
- Kaitlyn LovettMontgomery$286K
- Amy RossDayton$281K
- Renee OttSandusky$179K
- Megan MillerSpringfield$156K
- George KnightCincinnati$130K
- Jillian HuntCincinnati$116K
- Florence StewartNew Albany$113K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.